SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 19 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 33 | -99.9% | 0.00% | – |
| Q1 2017 | $23,000 | -14.8% | 36,033 | 0.0% | 0.00% | – |
| Q4 2016 | $27,000 | -56.5% | 36,033 | 0.0% | 0.00% | – |
| Q3 2016 | $62,000 | – | 36,033 | +109090.9% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 33 | -99.5% | 0.00% | – |
| Q1 2016 | $16,000 | -89.0% | 6,986 | -88.9% | 0.00% | – |
| Q4 2015 | $145,000 | +480.0% | 63,163 | +472.9% | 0.00% | – |
| Q3 2015 | $25,000 | +177.8% | 11,025 | +267.5% | 0.00% | – |
| Q2 2015 | $9,000 | -25.0% | 3,000 | -50.0% | 0.00% | – |
| Q1 2015 | $12,000 | +1100.0% | 6,000 | +500.0% | 0.00% | – |
| Q4 2014 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -96.9% | 1,000 | -96.0% | 0.00% | – |
| Q1 2014 | $64,000 | +33.3% | 24,803 | -11.8% | 0.00% | – |
| Q2 2013 | $48,000 | – | 28,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |